Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Enrollment begins in phase III Alzheimer's study of Flurizan

Jan. 14, 2005

BioAxone cleared to commence U.S. clinical development of Cethrin

Jan. 14, 2005

Safinamide shows promise in restless legs syndrome pilot study

Jan. 14, 2005

GSK team identifies new 5-HT5A receptor ligands for CNS disorders

Jan. 13, 2005

Researchers at Actelion disclose orexin receptor antagonists

Jan. 13, 2005

New agents for Alzheimer's disease claimed by De Novo

Jan. 13, 2005

Unique dual-binding AChE inhibitor with potent Abeta antiaggregating activity

Jan. 13, 2005

Phase III study planned for Mylinax in MS

Jan. 13, 2005

Muscarinic M1 receptor antagonists emerge from research at Lilly

Jan. 12, 2005

Valeant submits complete response for Zelapar

Jan. 12, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...